evolving biomarker driven therapies to overcome gastric cancer tumor resistance
Published 5 months ago • 148 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
1:27
biomarker-driven treatment strategies for her2 g/gej junction cancer
-
0:41
advancing oncology care: the evolving role of diagnostic labs in biomarker-driven therapies
-
3:45
why biomarkers matter for gastric cancer
-
5:24
emerging biomarkers in metastatic gastric cancer
-
4:15
the role of the trop2 biomarker in cancer
-
3:54
probio: a biomarker driven study in patients with metastatic prostate cancer
-
7:34
how do biomarker test results impact gastric cancer treatment options?
-
5:27
what are biomarkers? (cancer treatment options)
-
17:37
ask the expert: the role of biomarkers in stomach cancer | featuring dr. samuel klempner
-
5:42
evolving global treatment landscape for gastric cancer
-
3:58
how do biomarker test results impact a gastric cancer treatment plan?
-
24:10
early detection approaches for the family of gi cancers – 2020 stanford gastric cancer summit
-
0:59
a bacteria that causes ulcers and cancer? learn about h pylori
-
1:13:31
22 principles of biomarker testing: part 2 the liquid biopsy
-
51:14
stomach cancer webinar: molecular biomarkers, presented by samuel klempner, md
-
3:14
what is the role of biomarker testing in stomach cancer?
-
0:52
why biomarker testing is important in metastatic colorectal cancer!
-
19:13
31 first line therapy: the role of biomarkers and nccn guidelines